STIFEL FINANCIAL CORP

Q4 2022 13F-HR Holdings

Location
St. Louis, MO
Holdings as of
12/31/2022
Date filed
2/13/2023
Form type
13F-HR
Num holdings
3,284
Total value ($000)
$66,620,607
Net value change ($000)
+5,550,880 (9.1%)
New positions
185
Sold out positions
171
Turnover %
1.5%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
GOVT 361,705 611.5%
TSCO 295,999 1032.4%
MRK 200,375 28.5%
JPM 136,558 28.9%
LMT 128,376 27.0%
HD 126,652 19.0%
PG 125,587 25.5%
V 121,690 18.4%
EMR 120,366 34.9%
LIN 113,410 24.6%
Top Reduces (Value $000, Stocks/ETFs)
Biohaven Pharmaceutical Holding Co Ltd. -464,340 -100.0%
AGG -359,955 -59.0%
AMZN -272,314 -29.4%
AAPL -128,899 -7.0%
TSLA -97,762 -70.7%
GOOGL -97,651 -12.8%
META -72,413 -46.4%
BIL -60,098 -12.8%
IBTK -50,759 -72.3%
DUK -50,379 -43.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type